SENZIME Trademark

Trademark Overview

On Wednesday, October 30, 2019, a trademark application was filed for SENZIME with the United States Patent and Trademark Office. The USPTO has given the SENZIME trademark a serial number of 88673764. The federal status of this trademark filing is REGISTERED as of Tuesday, August 18, 2020. This trademark is owned by Senzime AB (publ.). The SENZIME trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and instruments for analyzing, measuring and monitoring neuromuscular transmission
senzime

General Information

Serial Number88673764
Word MarkSENZIME
Filing DateWednesday, October 30, 2019
Status700 - REGISTERED
Status DateTuesday, August 18, 2020
Registration Number6128465
Registration DateTuesday, August 18, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 2, 2020

Trademark Statements

Goods and ServicesMedical apparatus and instruments for analyzing, measuring and monitoring neuromuscular transmission

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSunday, November 3, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSenzime AB (publ.)
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressUPPSALA 75651
SE
Party NameSenzime AB (publ.)
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressUPPSALA 75651
SE
Party NameSenzime AB (publ.)
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressUPPSALA 75651
SE

Trademark Events

Event DateEvent Description
Tuesday, August 18, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, June 2, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 2, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 28, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 24, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, April 23, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 23, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, April 23, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, March 30, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 30, 2020NON-FINAL ACTION E-MAILED
Monday, March 30, 2020NON-FINAL ACTION WRITTEN
Friday, March 20, 2020DATA MODIFICATION COMPLETED
Friday, March 20, 2020ASSIGNED TO LIE
Monday, March 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 16, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 16, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, February 11, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, February 11, 2020LETTER OF SUSPENSION E-MAILED
Tuesday, February 11, 2020SUSPENSION LETTER WRITTEN
Tuesday, February 4, 2020ASSIGNED TO EXAMINER
Sunday, November 3, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 2, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

senzime monitoring neuromuscular transmission measuring analyzing apparatus instruments medical